Clinical Trial Update: TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TCR alpha-beta T-cell and CD19 B-cell depleted peripheral blood stem cell transplantation using the CliniMACS system for non-m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-malignant Hematologic Disorders

Drugs mentioned

• CliniMACS System
• TCR alpha-beta T-cell and CD19 B-cell depleted peripheral blood stem cell transplantation (TCR alpha-beta T-cell and CD19 B-cell depleted PBSC transplantation)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-Malignant Hematologic Disorders | Phase 2 | Status: TERMINATED | Results posted: 2021-02-24